Home / Business and Economy / Shilpa Medicare Profits Soar 40% in Q3 FY25
Shilpa Medicare Profits Soar 40% in Q3 FY25
6 Feb
Summary
- Net profit surged 40.28% to Rs 44.58 crore in December 2025 quarter.
- Sales increased by 28.32% to Rs 409.73 crore during the same period.
- Operating profit margin saw an increase to 27.81%.
Shilpa Medicare has reported a strong performance for the quarter ending December 2025. The pharmaceutical company witnessed a significant rise in its net profit, which grew by 40.28% to Rs 44.58 crore. This marks a substantial improvement from the Rs 31.78 crore net profit recorded in the corresponding quarter of the previous year, December 2024.
Revenue for the quarter ending December 2025 also showed considerable growth. Sales climbed by 28.32% to reach Rs 409.73 crore, up from Rs 319.30 crore in the December 2024 quarter. Alongside these revenue gains, Shilpa Medicare also saw an increase in its operating profit margin, which rose to 27.81% from 25.26% in the previous year.
